First COVID-19 Outpatients Receive Monoclonal Antibodies at UConn Health
The week of Dec. 7 marked a major milestone for UConn John Dempsey Hospital with its first COVID-19 outpatients successfully receiving monoclonal antibody therapies, recently authorized by the FDA for emergency use.
Chief of Infectious Diseases, Dr. Kevin Dieckhaus, while caring for patients at the newly established outpatient Therapeutic Infusion Center at UConn John Dempsey Hospital the week of Dec. 7. His Infectious Diseases team has offered the first infusions of monoclonal antibodies to COVID-19 outpatients at highest risk of severe disease progression and hospitalization (Photo shared by UConn Health staff). Copy Link